AI Insight
A study presented at ESC Congress 2026 found that using coronary artery calcium scores to guide statin therapy initiation resulted in similar rates of major cardiovascular events compared to using traditional risk factor assessment methods. The research suggests that coronary artery calcium scoring does not provide superior outcomes over conventional risk assessment approaches when determining which patients should begin statin treatment. Both strategies appear equally effective in preventing cardiovascular events.
Why it matters
This finding has important implications for clinical practice, as coronary artery calcium scanning involves additional imaging costs and radiation exposure. The results suggest that traditional risk factor assessment remains a valid and potentially more cost-effective approach for making statin therapy decisions in cardiovascular disease prevention.
Understand the Science
There was no difference in major cardiovascular events when statin initiation was based on coronary artery calcium compared with traditional risk factor assessment, according to results presented in a Hot Line session today at ESC Congress 2026.
Source: New data presented on the use of coronary artery calcium for cardiovascular risk assessment